Annual SG&A
$5.62 M
-$3.29 M-36.91%
31 December 2023
Summary:
Adial Pharmaceuticals annual selling, general & administrative expenses is currently $5.62 million, with the most recent change of -$3.29 million (-36.91%) on 31 December 2023. During the last 3 years, it has risen by +$546.20 thousand (+10.76%). ADIL annual SG&A is now -39.85% below its all-time high of $9.34 million, reached on 31 December 2021.ADIL Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.18 M
-$94.90 K-7.44%
30 September 2024
Summary:
Adial Pharmaceuticals quarterly selling, general & administrative expenses is currently $1.18 million, with the most recent change of -$94.90 thousand (-7.44%) on 30 September 2024. Over the past year, it has increased by +$29.00 thousand (+2.52%). ADIL quarterly SG&A is now -67.48% below its all-time high of $3.63 million, reached on 30 September 2018.ADIL Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$301.73 M
-$13.05 M-4.52%
30 September 2024
Summary:
Adial Pharmaceuticals TTM selling, general & administrative expenses is currently -$301.73 million, with the most recent change of -$13.05 million (-4.52%) on 30 September 2024. Over the past year, it has dropped by -$307.90 million (-4992.49%). ADIL TTM SG&A is now -2936.06% below its all-time high of $9.50 million, reached on 30 June 2022.ADIL TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADIL Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.9% | +2.5% | -4992.5% |
| 3 y3 years | +10.8% | -50.3% | -3587.3% |
| 5 y5 years | -15.1% | +33.8% | -6903.4% |
ADIL Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.9% | +10.8% | -54.0% | +12.6% | -96.2% | at low |
| 5 y | 5 years | -39.9% | +31.4% | -57.7% | +33.8% | -385.3% | at low |
| alltime | all time | -39.9% | +2023.5% | -67.5% | +1951.8% | -2936.1% | at low |
Adial Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.18 M(-7.4%) | $5.36 M(+0.5%) |
| June 2024 | - | $1.27 M(-8.3%) | $5.34 M(+4.4%) |
| Mar 2024 | - | $1.39 M(-8.5%) | $5.11 M(-9.1%) |
| Dec 2023 | $5.62 M(-36.9%) | $1.52 M(+32.0%) | $5.62 M(-8.9%) |
| Sept 2023 | - | $1.15 M(+9.9%) | $6.17 M(-10.3%) |
| June 2023 | - | $1.05 M(-45.0%) | $6.87 M(-18.1%) |
| Mar 2023 | - | $1.90 M(-7.9%) | $8.39 M(-6.2%) |
| Dec 2022 | $8.91 M(-4.7%) | $2.07 M(+11.1%) | $8.95 M(-0.4%) |
| Sept 2022 | - | $1.86 M(-27.5%) | $8.98 M(-5.4%) |
| June 2022 | - | $2.56 M(+4.1%) | $9.50 M(+5.3%) |
| Mar 2022 | - | $2.46 M(+17.3%) | $9.02 M(-3.5%) |
| Dec 2021 | $9.34 M(+84.1%) | $2.10 M(-11.5%) | $9.34 M(+8.0%) |
| Sept 2021 | - | $2.37 M(+13.8%) | $8.65 M(+11.3%) |
| June 2021 | - | $2.08 M(-25.2%) | $7.77 M(+17.4%) |
| Mar 2021 | - | $2.79 M(+98.2%) | $6.62 M(+30.5%) |
| Dec 2020 | $5.07 M | $1.41 M(-5.6%) | $5.07 M(+11.4%) |
| Sept 2020 | - | $1.49 M(+60.2%) | $4.55 M(+15.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $930.80 K(-25.0%) | $3.94 M(-0.4%) |
| Mar 2020 | - | $1.24 M(+39.9%) | $3.96 M(-7.5%) |
| Dec 2019 | $4.28 M(-35.3%) | $887.00 K(+0.6%) | $4.28 M(-3.5%) |
| Sept 2019 | - | $881.50 K(-7.1%) | $4.43 M(-38.2%) |
| June 2019 | - | $948.60 K(-39.3%) | $7.18 M(-9.1%) |
| Mar 2019 | - | $1.56 M(+49.9%) | $7.90 M(+19.3%) |
| Dec 2018 | $6.62 M(+713.9%) | $1.04 M(-71.3%) | $6.62 M(+13.2%) |
| Sept 2018 | - | $3.63 M(+117.9%) | $5.85 M(+138.3%) |
| June 2018 | - | $1.66 M(+486.1%) | $2.45 M(+152.4%) |
| Mar 2018 | - | $284.00 K(+5.3%) | $972.00 K(+19.5%) |
| Dec 2017 | $813.20 K(+207.2%) | $269.80 K(+15.0%) | $813.10 K(+34.8%) |
| Sept 2017 | - | $234.60 K(+27.8%) | $603.00 K(+40.5%) |
| June 2017 | - | $183.60 K(+46.8%) | $429.20 K(+41.6%) |
| Mar 2017 | - | $125.10 K(+109.5%) | $303.10 K(+70.3%) |
| Dec 2016 | $264.70 K(-46.8%) | $59.70 K(-1.8%) | $178.00 K(+50.5%) |
| Sept 2016 | - | $60.80 K(+5.7%) | $118.30 K(+105.7%) |
| June 2016 | - | $57.50 K | $57.50 K |
| Dec 2015 | $497.10 K | - | - |
FAQ
- What is Adial Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals annual SG&A year-on-year change?
- What is Adial Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals quarterly SG&A year-on-year change?
- What is Adial Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Adial Pharmaceuticals?
- What is Adial Pharmaceuticals TTM SG&A year-on-year change?
What is Adial Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of ADIL is $5.62 M
What is the all time high annual SG&A for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high annual selling, general & administrative expenses is $9.34 M
What is Adial Pharmaceuticals annual SG&A year-on-year change?
Over the past year, ADIL annual selling, general & administrative expenses has changed by -$3.29 M (-36.91%)
What is Adial Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of ADIL is $1.18 M
What is the all time high quarterly SG&A for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $3.63 M
What is Adial Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, ADIL quarterly selling, general & administrative expenses has changed by +$29.00 K (+2.52%)
What is Adial Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of ADIL is -$301.73 M
What is the all time high TTM SG&A for Adial Pharmaceuticals?
Adial Pharmaceuticals all-time high TTM selling, general & administrative expenses is $9.50 M
What is Adial Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, ADIL TTM selling, general & administrative expenses has changed by -$307.90 M (-4992.49%)